As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
On Friday, Reata Pharmaceuticals (NASDAQ:RETA), R. Kent McGaughy Jr., made a $484,016 buy of RETA, purchasing 17,000 shares at a cost of $28.47 a piece. Reata Pharmaceuticals Inc is trading off about 0.3% on the day Tuesday. Before this latest buy, McGaughy Jr. bought RETA at 2 other times during the past twelve months, for a total cost of $5.66M at an average of $24.93 per share.
And at Capital Southwest (NASDAQ:CSWC), there was insider buying on Thursday, by Director David R. Brooks who bought 2,000 shares for a cost of $16.66 each, for a total investment of $33,326. Before this latest buy, Brooks made one other buy in the past twelve months, purchasing $166,217 shares at a cost of $15.98 a piece. Capital Southwest is trading up about 1.9% on the day Tuesday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.